Authors: Trauzold, A Wermann, H Arlt, A Schutze, S Schafer, H Oestern, S Roder, C Ungefroren, H Lampe, E Heinrich, M Walczak, H Kalthoff, H

Citation: A. Trauzold et al., CD95 and TRAIL receptor-mediated activation of protein kinase C and NF-kappa B contributes to apoptosis resistance in ductal pancreatic adenocarcinoma cells, ONCOGENE, 20(31), 2001, pp. 4258-4269

Authors: Ungefroren, H Kruse, ML Trauzold, A Roeschmann, S Roeder, C Arlt, A Henne-Bruns, D Kalthoff, H

Citation: H. Ungefroren et al., FAP-1 in pancreatic cancer cells: functional and mechanistic studies on its inhibitory role in CD95-mediated apoptosis, J CELL SCI, 114(15), 2001, pp. 2735-2746

Authors: Grobe, O Arlt, A Ungefroren, H Krupp, G Folsch, UR Schmidt, WE Schafer, H

Citation: O. Grobe et al., Functional disruption of IEX-1 expression by concatemeric hammerhead ribozymes alters growth properties of 293 cells, FEBS LETTER, 494(3), 2001, pp. 196-200

Authors: Hinz, S Trauzold, A Boenicke, L Sandberg, C Beckmann, S Bayer, E Walczak, H Kalthoff, H Ungefroren, H

Citation: S. Hinz et al., Bcl-X-L protects pancreatic adenocarcinoma cells against CD95-and TRAIL-receptor-mediated apoptosis, ONCOGENE, 19(48), 2000, pp. 5477-5486

Authors: Ungefroren, H Jansen, M Henne-Bruns, D Kremer, B Kalthoff, H

Citation: H. Ungefroren et al., FAP-1 (Fas-associated phosphatase-1) protects pancreatic carcinoma cells from fas induced apoptosis, LANG ARCH S, 1999, pp. 275-278

Authors: Voss, M Wolff, B Savitskaia, N Ungefroren, H Deppert, W Schmiegel, W Kalthoff, H Naumann, M

Citation: M. Voss et al., TGF beta-induced growth inhibition involves cell cycle inhibitor p21 and pRb independent from p15 expression, INT J ONCOL, 14(1), 1999, pp. 93-101